Sunday, November 23, 2014 12:19:18 PM
Do you believe that eventual use of Kevetrin as monotherapy or in combination therapy impacts Cellceutix's valuation at this time? IMO, Kevetrin as a single agent would be great and I'd be very happy. And if another agent can be combined with Kevetrin to give even a slight benefit to a cancer patient, I'm all for it. It's no longer monotherapy but it's better for the patient. If Kevetrin can be used in combination with other agents for a wide variety of cancers then I'm thrilled. What's best for investors? If Kevetrin is eventually approved, they're all homeruns.
We have a long way to go in clinical trials and its eventual use as monotherapy or in combination does not impact my investment decision in any way. I'd be surprised if monotherapy vs. combination therapy for Kevetrin impacts the decisions of any investors at this stage.
Declaring an opinion over and over again does not make it fact.
btw, I note that you still haven't answered DrBones question about p21 levels that are necessary for substantial benefit. Good luck finding the answer and please let us know.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM